#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune thrombocytopenia Liver abscess Piriformis syndrome Anal squamous cell carcinoma Immunodeficiency Paraneoplastic neurological syndrome Pemphigus Neurofibroma Drug eruption Endometrial adenocarcinoma Penile cancer Congenital nephrogenic diabetes insipidus Sarcoidosis Extra-osseous Ewing's sarcoma metastatic Autoinflammation with infantile enterocolitis More trials…

    Learn about Rare Diseases

    Short-bowel syndrome – Basic Information Chondrosarcoma Gaucher’s disease type III – Trials in Disease Hereditary optic atrophy – Treatment Leiomyosarcoma Sarcoma Mitochondrial myopathy – Basic Information Haemophilia B without inhibitors – Diagnostics Skin angiosarcoma – Basic Information Primary immunodeficiency syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Kk8123 Ribonucleic Acid K30 Moxifloxacin Soft Paraffin And Fat Products Ondansetron Hydrochloride Threonine Vericiguat Abemaciclib Ro7589655 Estriol Alanine Potassium Oxybate Gallium (68Ga) Gozetotide Clenbuterol Hydrochloride Bi 1291583 Cellulose, Microcrystalline Apl-101 Carisbamate Sulfasalazine Prasinezumab More therapies…

    Learn about Your Condition

    Eye disorder Acute cardiac event Thalassaemia beta Thromboangiitis obliterans Seizure Pseudomonas infection Angiosarcoma recurrent Actinic keratosis Type 1 diabetes mellitus Breast proliferative changes Blood iron increased Colorectal cancer stage III Cervix carcinoma recurrent Fibrosarcoma Osteosarcoma metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Safety and Effectiveness of PolyCore (Xylitol, L-Carnitine, Polydextrin) for Patients with End-Stage Kidney Disease Starting Peritoneal Dialysis

    Recruiting

    2 1 1
    Investigated Diseases:
    • End stage renal disease
    Investigated Drugs:
    • Lactic Acid
    • Levocarnitine
    • Magnesium Chloride Hexahydrate
    Italy

  • Study on the Effects of THC and CBD Oral Solution for Chronic Neuropathic Pain in Multiple Sclerosis Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Neuralgia
    • Multiple sclerosis
    Investigated Drugs:
    • Dronabinol
    • Cannabidiol
    Portugal

  • Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Advanced or Recurrent Endometrial Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Cimetidine Hydrochloride
    • Buclizine Hydrochloride
    • Carboplatin
    Austria Belgium Czechia Denmark Finland France +10

  • Study on the Effectiveness and Safety of Pirtobrutinib and Rituximab for Untreated Adult Patients with Indolent Mantle Cell Lymphoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Pirtobrutinib
    • Rituximab
    Portugal Spain

  • Study on the Effectiveness of Ixekizumab for Patients with Refractory Psoriatic Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Ixekizumab
    Italy

  • Study of Belatacept versus Tacrolimus in Kidney Transplant Recipients with Subclinical Antibody Mediated Rejection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Belatacept
    • Tacrolimus
    France
Previous Page
1 … 177 178 179 180 181 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!